The carmaker says revenue in China fell by almost half and US tariffs pressured margins; it is targeting a further SEK 5bn in savings, with 2,000 of the cuts in Sweden.
The airbag and seatbelt maker leaned on India and Chinese carmakers in Q3 2026, cut its margin outlook to the low end of its range and kept organic growth guidance at around 0%.
The Shanghai- and Cambridge, Massachusetts-based drugmaker is selling 11.34 million ADSs at $22.04 each, with closing expected on or about 27 October 2026.